Phone: (650) 368 6983
info@airmid.com
Under Construction
July 2009
AIRMID partners with Kineta
to develop ShK peptides
February 2009
Adam Bristol joins
AIRMID Board of Directors
more...
Home
|
Autoimmune disease
|
Multiple sclerosis
|
Type 1 diabetes mellitus
|
Kv1.3 Potassium Channel
|
PAP-1
|
ShK
Effector memory T cells
|
Contact
|
Sitemap
Copyrights © 2007, www.airmid.com